These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 32687408

  • 1. Effects of tumor types on treatment strategy formulation and prognostic evaluation of gastric neuroendocrine tumors.
    Jiao X, Wang Z, Peng X, Zhang L, Zhou L.
    Future Oncol; 2020 Oct; 16(28):2197-2207. PubMed ID: 32687408
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.
    Karakaş Y, Laçin Ş, Kurtulan O, Esin E, Sunar V, Sökmensüer C, Kılıçkap S, Yalçin Ş.
    Turk J Gastroenterol; 2020 Feb; 31(2):91-98. PubMed ID: 32141816
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
    Scherübl H, Cadiot G, Jensen RT, Rösch T, Stölzel U, Klöppel G.
    Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
    [Abstract] [Full Text] [Related]

  • 8. Gastric Neuroendocrine Tumors (Carcinoids).
    Gluckman CR, Metz DC.
    Curr Gastroenterol Rep; 2019 Mar 12; 21(4):13. PubMed ID: 30868284
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.
    Yang Z, Wang W, Lu J, Pan G, Pan Z, Chen Q, Liu W, Zhao Y.
    Cell Physiol Biochem; 2018 Mar 12; 45(1):389-396. PubMed ID: 29402806
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neuroendocrine Tumors of the Stomach.
    Corey B, Chen H.
    Surg Clin North Am; 2017 Apr 12; 97(2):333-343. PubMed ID: 28325190
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.
    Chen WC, Warner RR, Ward SC, Harpaz N, Divino CM, Itzkowitz SH, Kim MK.
    Dig Dis Sci; 2015 Apr 12; 60(4):996-1003. PubMed ID: 25399327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
    Yang M, Tian BL, Zhang Y, Su AP, Yue PJ, Xu S, Wang L.
    Pancreas; 2014 Oct 12; 43(7):1003-8. PubMed ID: 24945681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.